Denali Therapeutics Inc. (DNLI) Q2 2024 Earnings
DNLI·Reported August 1, 2024·Before market open
Diluted EPS came in at $-0.59, beat the $-0.68 consensus by $0.09.
Diluted EPS
$-0.59beat by $0.09
Consensus: $-0.68
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Denali Therapeutics Inc.'s Q2 2024 earnings report.
Denali Therapeutics Inc. (DNLI) reported Q2 2024 earnings on August 1, 2024 before market open.
Denali Therapeutics Inc. reported diluted EPS of $-0.59 for Q2 2024.
EPS beat the consensus estimate of $-0.68 by $0.09.
You can read the 10-Q periodic report (0001714899-24-000169) directly on SEC EDGAR. The filing index links above go to sec.gov.